• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由产志贺毒素2d的大肠杆菌O80:H2引起的罕见严重溶血尿毒综合征病例。

Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2.

作者信息

Wijnsma Kioa L, Schijvens Anne M, Rossen John W A, Kooistra-Smid A M D Mirjam, Schreuder Michiel F, van de Kar Nicole C A J

机构信息

Department of Paediatric Nephrology, Radboud University Medical Center, Amalia Children's Hospital, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.

Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.

出版信息

Pediatr Nephrol. 2017 Jul;32(7):1263-1268. doi: 10.1007/s00467-017-3642-3. Epub 2017 Mar 25.

DOI:10.1007/s00467-017-3642-3
PMID:28343354
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5440534/
Abstract

BACKGROUND

Hemolytic uremic syndrome (HUS) is one of the most common causes of acute renal failure in children, with the majority of cases caused by an infection with Shiga toxin-producing Escherichia coli (STEC). Whereas O157 is still the predominant STEC serotype, non-O157 serotypes are increasingly associated with STEC-HUS. However, little is known about this emerging and highly diverse group of non-O157 serotypes. With supportive therapy, STEC-HUS is often self-limiting, with occurrence of chronic sequelae in just a small proportion of patients.

CASE DIAGNOSIS/TREATMENT: In this case report, we describe a 16-month-old boy with a highly severe and atypical presentation of STEC-HUS. Despite the presentation with multi-organ failure and extensive involvement of central nervous system due to extensive thrombotic microangiopathy (suggestive of atypical HUS), fecal diagnostics revealed an infection with the rare serotype: shiga toxin 2d-producing STEC O80:H2.

CONCLUSIONS

This report underlines the importance of STEC diagnostic tests in all children with HUS, including those with an atypical presentation, and emphasizes the importance of molecular and serotyping assays to estimate the virulence of an STEC strain.

摘要

背景

溶血尿毒综合征(HUS)是儿童急性肾衰竭最常见的病因之一,大多数病例由产志贺毒素大肠杆菌(STEC)感染引起。虽然O157仍然是主要的STEC血清型,但非O157血清型与STEC-HUS的关联日益增加。然而,对于这一新兴且高度多样化的非O157血清型群体,人们知之甚少。通过支持性治疗,STEC-HUS通常具有自限性,仅有一小部分患者会出现慢性后遗症。

病例诊断/治疗:在本病例报告中,我们描述了一名16个月大的男孩,他患有高度严重且非典型的STEC-HUS。尽管因广泛血栓性微血管病出现多器官功能衰竭和中枢神经系统广泛受累(提示非典型HUS),粪便诊断显示感染了罕见血清型:产志贺毒素2d的STEC O80:H2。

结论

本报告强调了对所有HUS患儿进行STEC诊断检测的重要性,包括那些非典型表现的患儿,并强调了分子和血清分型检测对于评估STEC菌株毒力的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e47/5440534/f643ba0cbed8/467_2017_3642_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e47/5440534/f643ba0cbed8/467_2017_3642_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e47/5440534/f643ba0cbed8/467_2017_3642_Fig1_HTML.jpg

相似文献

1
Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2.由产志贺毒素2d的大肠杆菌O80:H2引起的罕见严重溶血尿毒综合征病例。
Pediatr Nephrol. 2017 Jul;32(7):1263-1268. doi: 10.1007/s00467-017-3642-3. Epub 2017 Mar 25.
2
Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.产志贺毒素大肠杆菌感染导致的溶血性尿毒症综合征。
Med Mal Infect. 2018 May;48(3):167-174. doi: 10.1016/j.medmal.2017.09.012. Epub 2017 Oct 18.
3
CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).一例志贺毒素相关性溶血尿毒综合征(STEC-HUS)中的CFH基因突变
Pediatr Nephrol. 2016 Jan;31(1):157-61. doi: 10.1007/s00467-015-3207-2. Epub 2015 Sep 23.
4
Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.应用补体单克隆抗体依库珠单抗治疗产志贺毒素大肠埃希菌相关性溶血尿毒综合征:对现有证据的综述。
Pediatr Blood Cancer. 2019 Nov;66(11):e27913. doi: 10.1002/pbc.27913. Epub 2019 Jul 9.
5
Serotypes and virulence profiles of Shiga toxin-producing Escherichia coli strains isolated during 2017 from human infections in Switzerland.2017 年瑞士人感染病例中分离出的产志贺毒素大肠杆菌菌株的血清型和毒力特征。
Int J Med Microbiol. 2018 Oct;308(7):933-939. doi: 10.1016/j.ijmm.2018.06.011. Epub 2018 Jun 30.
6
Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.2000 年至 2016 年芬兰儿童患者与无溶血尿毒症综合征患者中产志贺毒素大肠埃希菌的比较基因组学研究。
Microbiol Spectr. 2022 Aug 31;10(4):e0066022. doi: 10.1128/spectrum.00660-22. Epub 2022 Jun 22.
7
Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.志贺毒素 1 是否对儿童志贺毒素 2 相关溶血尿毒综合征的发展具有保护作用?来自 ItalKid-HUS 网络的数据。
Pediatr Nephrol. 2020 Oct;35(10):1997-2001. doi: 10.1007/s00467-020-04697-y. Epub 2020 Jul 30.
8
Genome-wide association study of hemolytic uremic syndrome causing Shiga toxin-producing Escherichia coli from Sweden, 1994-2018.1994 年至 2018 年瑞典产志贺毒素大肠杆菌引起溶血性尿毒综合征的全基因组关联研究。
Eur J Clin Microbiol Infect Dis. 2023 Jun;42(6):771-779. doi: 10.1007/s10096-023-04600-1. Epub 2023 Apr 27.
9
Characteristics of Shiga toxin producing- and enteropathogenic Escherichia coli of the emerging serotype O80:H2 isolated from humans and diarrhoeic calves in Belgium.从人类和比利时腹泻犊牛中分离出的新型血清型 O80:H2 产志贺毒素和肠致病性大肠杆菌的特征。
Clin Microbiol Infect. 2019 Jan;25(1):111.e5-111.e8. doi: 10.1016/j.cmi.2018.07.023. Epub 2018 Aug 1.
10
Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing , an overview of 10 years of surveillance in France, 2007 to 2016.小儿溶血尿毒综合征与产志贺毒素大肠埃希菌相关:法国 2007 至 2016 年十年监测概述。
Euro Surveill. 2019 Feb;24(8). doi: 10.2807/1560-7917.ES.2019.24.8.1800068.

引用本文的文献

1
O80:H2-Associated Hemolytic Uremic Syndrome without Hemorrhagic Colitis: A Case Report.O80:H2相关的无出血性结肠炎的溶血尿毒综合征:一例报告
Case Rep Nephrol Dial. 2024 Jun 26;14(1):97-103. doi: 10.1159/000539403. eCollection 2024 Jan-Dec.
2
Genetic and virulence characteristics of hybrid Shiga toxin-producing and atypical enteropathogenic strains isolated in South Korea.韩国分离的产志贺毒素杂交菌株和非典型肠致病性菌株的遗传及毒力特征
Front Microbiol. 2024 May 15;15:1398262. doi: 10.3389/fmicb.2024.1398262. eCollection 2024.
3
First Isolation of the Heteropathotype Shiga Toxin-Producing and Extra-Intestinal Pathogenic (STEC-ExPEC) O80:H2 in French Healthy Cattle: Genomic Characterization and Phylogenetic Position.

本文引用的文献

1
Enterohemorrhagic Escherichia coli Hybrid Pathotype O80:H2 as a New Therapeutic Challenge.肠出血性大肠杆菌杂交致病型O80:H2——一种新的治疗挑战
Emerg Infect Dis. 2016 Sep;22(9):1604-12. doi: 10.3201/eid2209.160304.
2
Fecal diagnostics in combination with serology: best test to establish STEC-HUS.粪便诊断与血清学相结合:用于确诊产志贺毒素大肠杆菌相关性溶血尿毒综合征的最佳检测方法。
Pediatr Nephrol. 2016 Nov;31(11):2163-70. doi: 10.1007/s00467-016-3420-7. Epub 2016 May 30.
3
Comprehensive Characterization of Escherichia coli O104:H4 Isolated from Patients in the Netherlands.
首次从法国健康牛中分离出产志贺毒素和肠外致病性(STEC-ExPEC)O80:H2 异型体:基因组特征和系统发育位置。
Int J Mol Sci. 2024 May 16;25(10):5428. doi: 10.3390/ijms25105428.
4
Pathogenic Factors and Recent Study on the Rapid Detection of Shiga Toxin-Producing Escherichia coli (STEC).产志贺毒素大肠杆菌(STEC)的致病因素及快速检测的最新研究
Mol Biotechnol. 2025 Jan;67(1):16-26. doi: 10.1007/s12033-023-00985-8. Epub 2023 Dec 28.
5
Molecular Characterization of Hetero-Pathogenic and Diarrheagenic Pathotypes in Diarrheic Children under Five Years and Exposure Environment in Ogun State, South-West Nigeria.尼日利亚西南部奥贡州五岁以下腹泻儿童的异源致病性和致腹泻型别以及暴露环境的分子特征分析
Pathogens. 2023 Nov 15;12(11):1358. doi: 10.3390/pathogens12111358.
6
Transforming Shiga toxin-producing surveillance through whole genome sequencing in food safety practices.通过全基因组测序转变食品安全实践中对产志贺毒素菌株的监测。
Front Microbiol. 2023 Jul 13;14:1204630. doi: 10.3389/fmicb.2023.1204630. eCollection 2023.
7
Virulence of Shigatoxigenic and Enteropathogenic O80:H2 in Larvae: Comparison of the Roles of the pS88 Plasmids and STX2d Phage.产志贺毒素和肠致病性O80:H2对幼虫的毒力:pS88质粒和STX2d噬菌体作用的比较
Vet Sci. 2023 Jun 29;10(7):420. doi: 10.3390/vetsci10070420.
8
O80 in Healthy Cattle: Absence of Shigatoxigenic and Enteropathogenic O80:H2 and (Phylo) Genomics of Non-Clonal Complex 165 O80.健康牛中的O80:志贺毒素产生性和肠致病性O80:H2的缺失以及非克隆复合体165 O80的(系统发育)基因组学
Microorganisms. 2023 Jan 17;11(2):230. doi: 10.3390/microorganisms11020230.
9
Safety and Immunogenicity of a Chimeric Subunit Vaccine against Shiga Toxin-Producing in Pregnant Cows.抗产志贺毒素大肠埃希氏菌嵌合亚单位疫苗在妊娠奶牛中的安全性和免疫原性。
Int J Mol Sci. 2023 Feb 1;24(3):2771. doi: 10.3390/ijms24032771.
10
Impact of Shiga-toxin encoding gene transduction from O80:H2 Shiga toxigenic Escherichia coli (STEC) on non-STEC strains.O80:H2 志贺样毒素大肠杆菌(STEC)源性志贺毒素编码基因转导对非 STEC 菌株的影响。
Sci Rep. 2022 Dec 14;12(1):21587. doi: 10.1038/s41598-022-26198-8.
从荷兰患者中分离出的大肠杆菌O104:H4的全面特征分析
Front Microbiol. 2015 Dec 2;6:1348. doi: 10.3389/fmicb.2015.01348. eCollection 2015.
4
Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposal.产志贺毒素大肠杆菌(VTEC)感染的抗生素治疗:一项系统评价及建议
J Antimicrob Chemother. 2015 Sep;70(9):2440-6. doi: 10.1093/jac/dkv162. Epub 2015 Jun 20.
5
Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement.依库珠单抗治疗伴有神经受累的典型溶血性尿毒症综合征(HUS)
Medicine (Baltimore). 2015 Jun;94(24):e1000. doi: 10.1097/MD.0000000000001000.
6
Assessing the public health risk of Shiga toxin-producing Escherichia coli by use of a rapid diagnostic screening algorithm.使用快速诊断筛查算法评估产志贺毒素大肠杆菌的公共卫生风险。
J Clin Microbiol. 2015 May;53(5):1588-98. doi: 10.1128/JCM.03590-14. Epub 2015 Mar 4.
7
Eculizumab hepatotoxicity in pediatric aHUS.依库珠单抗在儿童非典型溶血性尿毒症综合征中的肝毒性。
Pediatr Nephrol. 2015 May;30(5):775-81. doi: 10.1007/s00467-014-2990-5. Epub 2014 Nov 22.
8
Haemolytic-uraemic syndrome with bacteraemia caused by a new hybrid Escherichia coli pathotype.由新型杂交大肠杆菌致病型引起的伴有菌血症的溶血尿毒综合征
New Microbes New Infect. 2014 Jul;2(4):127-31. doi: 10.1002/nmi2.49. Epub 2014 May 27.
9
Hemolytic uremic syndrome.溶血尿毒综合征
Semin Immunopathol. 2014 Jul;36(4):399-420. doi: 10.1007/s00281-014-0416-x. Epub 2014 Feb 14.
10
Eculizumab in atypical hemolytic-uremic syndrome.依库珠单抗治疗非典型溶血性尿毒症综合征
N Engl J Med. 2013 Oct 3;369(14):1379-80. doi: 10.1056/NEJMc1308826.